Search
Virtus Biotech Clinical Trials ETF
BBCAdd to Watchlist
43.020USD
+2.290+5.62%
Close 11-06 16:00（ET）
2.81KVolume
119.12KTurnover
Today
+5.62%
5 Days
-0.07%
1 Month
-0.62%
6 Months
-2.71%
Year to Date
+11.57%
1 Year
+47.35%
Key Figures
41.010Open
40.730Prev. Close
43.430High
40.700Low
2.81KVolume
119.12KTurnover
0.04Volume Ratio
56.18052wk High
28.24852wk Low
18.84KAvg Volume
1.61%Div Yield
0.655Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
41.199NAV
USDNAV Currency
3.10P/B
--Price to earnings ratio
Virtus Biotech Clinical Trials ETF Profile
Ticker SymbolBBC
Asset ClassEquity
Fund ManagerVirtus
DomicileUS
Expense Ratio0.65%
Founded at2014-12-16
Tracking IndexLifeSci Biotechnology Clinical Trials Index
BBC was created on 2014-12-16 by Virtus. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 40.88m in AUM and 130 holdings. BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
Kodiak Sciences Inc
KOD
99.300
+8.280
+9.10%
9.32K
2.08%
$816.45K
First Tracks Biotherapeutics Inc
TRAX
47.900
+2.470
+5.44%
17.99K
2.02%
$792.41K
AbCellera Biologics Inc Ordinary Shares
ABCL
11.880
+0.750
+6.74%
60.56K
1.83%
$715.82K
4
Xencor Inc
XNCR
35.750
+1.700
+4.99%
25.74K
1.65%
$648.06K
5
Amylyx Pharmaceuticals Inc
AMLX
29.500
+1.880
+6.81%
21.75K
1.51%
$591.60K
6
ORIC Pharmaceuticals Inc
ORIC
8.820
+0.330
+3.89%
38.37K
1.29%
$505.36K
7
SpyGlass Pharma Inc
SGP
36.945
+2.865
+8.41%
17.21K
1.25%
$490.11K
8
Nurix Therapeutics Inc Ordinary Shares
NRIX
15.300
+0.460
+3.10%
18.72K
1.21%
$474.42K
9
SELLAS Life Sciences Group Inc
SLS
8.420
+0.540
+6.85%
40.53K
1.19%
$467.69K
10
Veradermics Inc
MANE
138.780
+10.180
+7.92%
3.30K
1.17%
$458.39K
Virtus Biotech Clinical Trials ETF Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral
Virtus Biotech Clinical Trials ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Virtus Biotech Clinical Trials ETF (BBC)?
The current price of Virtus Biotech Clinical Trials ETF (BBC) is 43.02. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of Virtus Biotech Clinical Trials ETF?
The 52-week high of Virtus Biotech Clinical Trials ETF is 56.18. Please refer to the page timestamp for the latest data.
What is the 52-week low of Virtus Biotech Clinical Trials ETF?
The 52-week low of Virtus Biotech Clinical Trials ETF is 28.25. Please refer to the page timestamp for the latest data.
What is the NAV of Virtus Biotech Clinical Trials ETF?
The NAV of Virtus Biotech Clinical Trials ETF is 41.20 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is Virtus Biotech Clinical Trials ETF (BBC) performing?
The trading turnover of Virtus Biotech Clinical Trials ETF (BBC) is 119.12K. Its price changed by -0.49% over the past month, while its one-year return is 45.72%. View the Virtus Biotech Clinical Trials ETF price chart for more details.
Is Virtus Biotech Clinical Trials ETF (BBC) a safe investment?
No investment is completely risk-free. The risk level of Virtus Biotech Clinical Trials ETF (BBC) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.